NovAliX News and Resources

NovAliX, a French preclinical Contract Research Organisation (CRO), has formed a new partnership with Massachusetts-based Bruker Corporation. Announced on 7 August, Bruker has made a minority investment in NovAliX, which will bolster the CRO’s capabilities in biophysics and drug discovery.